Insights

Gathering insights about Neuroderm…

Similar companies to Neuroderm

Neuroderm Tech Stack

Neuroderm uses 8 technology products and services including Umbraco, Cloudflare, Twemoji, and more. Explore Neuroderm's tech stack below.

Umbraco
Content Management System
Cloudflare
Content Management System
Twemoji
Font Scripts
ScrollReveal
Javascript Libraries
Lodash
Javascript Libraries
PHP
Programming Languages
reCAPTCHA
Security
Google Tag Manager
Tag Management

Media & News

NeuroDerm Ltd. has issues with résultats positifs de l'essai BouNDless de phase 3 évaluant le ND0612 chez des patients atteints de la maladie de Parkinson présentant des fluctuations motrices.
NeuroDerm annonce la publication des résultats positifs de l'essai BouNDless de phase 3 évaluant le ND0612 chez des patients atteints de la maladie de Parkinson présentant des fluctuations motrices.
Mar 18, 2024 | www.prnewswire.com
Mitsubishi Tanabe Pharma Europe Ltd acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.
Dr. Yaar is a serial entrepreneur, who served as founder and former CEO at Neuroderm, an Israeli pharmaceutical company acquired by Mitsubishi Tanabe Pharma in 2017 for $1.1 billion.
Nov 19, 2018 | www.biospace.com
Mitsubishi Tanabe Pharma America, Inc. acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.
NeuroDerm Ltd. (Nasdaq: NDRM ), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced today the completion of the previously announced acquisition of NeuroDerm by Mitsubishi Tanabe Pharma Corporation (TSE Code: 4508), a publicly traded company on the Tokyo Stock Exchange (“MTPC”).
Oct 17, 2017 | globenewswire.com
NeuroDerm Ltd. is developing drug-device combinations for central nervous system disorders.
NeuroDerm is a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders.
Jul 24, 2017 | www.globes.co.il
Mitsubishi Tanabe Pharma Corporation acquired NeuroDerm Ltd. for $1.1B on Jul 1st '17.
NeuroDerm Ltd. (Nasdaq: NDRM ), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that it has signed a definitive agreement under which Mitsubishi Tanabe Pharma Corporation (TSE Code:4508) (“MTPC”), a publicly traded company on the Tokyo Stock Exchange, will acquire NeuroDerm for US$39 per share in cash.
Jul 22, 2017 | globenewswire.com
NeuroDerm Ltd. received award Scientific Advice Letter on Jun 6th '17.
NeuroDerm Ltd. (Nasdaq: NDRM ), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that it has received a Scientific Advice Letter from the Scientific Advice Working Party of the European Medicines Agency (EMA).
Jun 06, 2017 | globenewswire.com

Neuroderm's Email Address Formats

Neuroderm uses at least 1 format(s):

Neuroderm Email Formats	Example	Percentage
First@neuroderm.com	John@neuroderm.com	85%
Last@neuroderm.com	Doe@neuroderm.com	8%
FirstL@neuroderm.com	JohnD@neuroderm.com	4%
FLast@neuroderm.com	JDoe@neuroderm.com	3%

Frequently Asked Questions

What is Neuroderm's phone number?

You can contact Neuroderm's main corporate office by phone at

+972-8-946-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neuroderm's official website and social media links?

Neuroderm's official website is neuroderm.com and has social profiles on LinkedIn Crunchbase.

What is Neuroderm's NAICS code?

Neuroderm's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Neuroderm have currently?

As of December 2025, Neuroderm has approximately 171 employees across 4 continents, including AsiaEuropeNorth America. Key team members include Chief Executive Officer: K. I.Chief Technology Officer: U. D.Vp Human Resources: A. N.. Explore Neuroderm's employee directory with LeadIQ.

What industry does Neuroderm belong to?

Neuroderm operates in the Pharmaceutical Manufacturing industry.

What technology does Neuroderm use?

Neuroderm's tech stack includes UmbracoCloudflareTwemojiScrollRevealLodashPHPreCAPTCHAGoogle Tag Manager.

What is Neuroderm's email format?

Neuroderm's email format typically follows the pattern of First@neuroderm.com. Find more Neuroderm email formats with LeadIQ.

How much funding has Neuroderm raised to date?

As of December 2025, Neuroderm has raised $75M in funding. The last funding round occurred on Dec 07, 2016 for $75M.

When was Neuroderm founded?

Neuroderm was founded in 2003.

Neuroderm

Q: What is Neuroderm's official website and social media links?

Neuroderm's official website is neuroderm.com. Neuroderm has social profiles on LinkedIn.

Q: How many employees does Neuroderm have currently?

Neuroderm has approximately 171 employees.

Q: What technology does Neuroderm use?

Neuroderm's tech stack includes cdnjs, WordPress, Hammer.js, Bootstrap, Windows Server.

Pharmaceutical ManufacturingCentral District, Israel51-200 Employees

NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.

By developing next-generation drug-device combination solutions for central nervous system disorders, we aspire to make a meaningful difference in patients’ lives and drive future healthcare connectivity.

Our mission is to address the challenges of the future healthcare and wellbeing ecosystem. We are passionately driven to reduce disease burden and improve the quality of life of patients and their families through innovative drug-device combination therapies and technologies.

Company Overview

Phone number: +972-8-946-****
Website: neuroderm.com
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Founded: 2003
Employees: 51-200

Media & News

Funding & Financials

$75M
Neuroderm has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Dec 07, 2016 in the amount of $75M.
$50M$100M
Neuroderm's revenue is estimated to be in the range of $50M$100M

Funding & Financials

$75M
Neuroderm has raised a total of $75M of funding over 4 rounds. Their latest funding round was raised on Dec 07, 2016 in the amount of $75M.
$50M$100M
Neuroderm's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Neuroderm

Microbiome Therapeutics

Q/C Technologies

Intra-Cellular Therapies

Lundbeck

Neuroderm Tech Stack

Media & News

NeuroDerm Ltd. has issues with résultats positifs de l'essai BouNDless de phase 3 évaluant le ND0612 chez des patients atteints de la maladie de Parkinson présentant des fluctuations motrices.

Mitsubishi Tanabe Pharma Europe Ltd acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.

Mitsubishi Tanabe Pharma America, Inc. acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.

NeuroDerm Ltd. is developing drug-device combinations for central nervous system disorders.

Mitsubishi Tanabe Pharma Corporation acquired NeuroDerm Ltd. for $1.1B on Jul 1st '17.

NeuroDerm Ltd. received award Scientific Advice Letter on Jun 6th '17.

Neuroderm's Email Address Formats

Frequently Asked Questions

What is Neuroderm's phone number?

What is Neuroderm's official website and social media links?

What is Neuroderm's NAICS code?

How many employees does Neuroderm have currently?

What industry does Neuroderm belong to?

What technology does Neuroderm use?

What is Neuroderm's email format?

How much funding has Neuroderm raised to date?

When was Neuroderm founded?

Neuroderm

Company Overview

Media & News

NeuroDerm Ltd. has issues with résultats positifs de l'essai BouNDless de phase 3 évaluant le ND0612 chez des patients atteints de la maladie de Parkinson présentant des fluctuations motrices.

Mitsubishi Tanabe Pharma Europe Ltd acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.

Mitsubishi Tanabe Pharma America, Inc. acquired NeuroDerm Ltd. for $1.1B on Jan 1st '17.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?